534 / 1084
Ongoing trial
CALGB 80803, NCT01333033
Post-induction chemotherapy PET
choice of the chemotherapy regimen during subsequent chemoradiotherapy
followed by surgery
Preliminary report presented at the 2017 ASCO GI Cancers Symposium
- PET non responders who crossed over to an alternative chemotherapy
regimen had a higher pathologic complete response (CR) rate than did those
who continued the same regimen
Goodman KA, Niedzwiecki D, Hall N, et al. Initial results of CALGB 80803 (Alliance): A randomized phase II
trial of PET scan-directed combined modality therapy for esophageal cancer (abstract). J Clin Oncol 35, 2017
(suppl 4S; abstract 1)